肌酸酐测定市场－全球产业规模、份额、趋势、机会和预测，按测试类型、按产品、按样本、按最终用户、按地区和竞争细分，2020 年至 2030 年

2024 年全球肌酸酐测定市场价值为 6.4029 亿美元，预计到 2030 年将达到 9.8715 亿美元，预测期内的复合年增长率为 7.48%。肌酸酐测量测试用于评估人体的肾功能。肌酸酐是一种化学化合物，在肌肉产生能量后仍留在体内。透过测量血液和尿液样本中的肌酸酐水平，可以确定肾臟在过滤肌酸酐时的状况。在成人中，正常的肌酸酐测量范围是每分升血液 0.5 至 1.2 毫克。肌酸酐水平较高表示肾臟状况不健康。由于生活条件恶劣，世界各地肾臟疾病的盛行率不断上升，尤其是在发展中国家，导致对肌酸酐测量测试的需求不断增长。此外，检测试剂盒和试剂的成本效益和易得性也促进了市场成长。

关键市场驱动因素

肾臟相关健康问题日益严重

主要市场挑战

缺乏对肌酸酐检测方法的认识

主要市场趋势

即时检验

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球肌酸酐测定市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依测试类型（Jaffe 动力学法、酵素法）
  • 依产品（试剂、试剂盒）
  • 通过样本（血液/血清、尿液）
  • 按最终使用者（医院、诊断实验室）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美肌酸酐测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲肌酸酐测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太地区肌酸酐测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲肌酸酐测定市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲肌酸酐测定市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

第 13 章：全球肌酸酐测定市场：SWOT 分析

第 14 章：竞争格局

• Abbott Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Quidel Corporation
• Cell Biolabs, Inc.
• Genway Biotech
• Randox Laboratories Ltd.
• ACON Laboratories
• Nova Biomedical
• Sysmex India Pvt. Ltd.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Creatinine Assay Market was valued at USD 640.29 Million in 2024 and is expected to reach USD 987.15 Million by 2030 with a CAGR of 7.48% during the forecast period. The creatinine measurement test is performed to assess renal function in the human body. Creatinine is a chemical compound that remains in the body after energy production in the muscles. By measuring creatinine levels in blood and urine samples, the status of the kidneys can be determined as they filter out creatinine. In adults, a normal creatinine measurement ranges from 0.5 to 1.2 milligrams per deciliter of blood. Higher levels of creatinine indicate unhealthy kidney conditions. The increasing prevalence of kidney diseases worldwide, particularly in developing countries, due to unfavorable living conditions, has led to a growing demand for creatinine measurement tests. Additionally, the cost-effectiveness and easy availability of test kits and reagents are contributing to market growth.

Key Market Drivers

Growing Kidney Related Health Problems

Kidney disorder, particularly chronic kidney disease (CKD), is a prominent contributor to global mortality rates. Timely diagnosis and appropriate treatment are crucial in preventing complications. Creatinine testing methods are employed to assess renal functionality. Key market players are prioritizing the production of high-quality products to meet the growing demand. Additionally, the continual increase in research activities in this field is propelling the global market's expansion. With an increasing number of people being diagnosed with kidney-related diseases, there is a higher demand for creatinine testing to assess kidney function and monitor disease progression. Patients with kidney diseases require regular monitoring of their kidney function, including creatinine levels. This ongoing monitoring drives the need for frequent creatinine testing. Creatinine assays are routinely performed in hospitals, clinics, and other healthcare facilities to assess kidney function in patients admitted with kidney-related issues or undergoing treatments that may impact kidney function. The need for rapid results and immediate clinical decision-making in critical care settings has driven the adoption of point-of-care creatinine testing, allowing for timely patient management. In the pharmaceutical industry, creatinine assays are utilized in pre-clinical and clinical research to assess the impact of new drugs on kidney function and potential nephrotoxicity. As awareness about kidney health increases, more people are undergoing routine health check-ups that include creatinine testing to identify early signs of kidney dysfunction which is boosting the global creatinine assay market.

Key Market Challenges

Lack Of Awareness About Creatinine Testing Methods

Many patients may not be aware of the importance of creatinine testing in assessing kidney function and may not understand its significance in their overall health. Different healthcare settings may use various methods for creatinine testing, leading to confusion among patients and providers about the accuracy and reliability of results. In some cases, healthcare providers may prioritize other health parameters over creatinine testing, potentially overlooking early signs of kidney dysfunction. Public health initiatives and awareness campaigns may not adequately address the importance of kidney health and creatinine testing in promoting overall well-being.

Key Market Trends

Point-of-Care Testing

POCT can be performed at the patient's bedside, in outpatient clinics, or even in remote or resource-limited areas. It eliminates the need for patients to visit a centralized laboratory for creatinine testing, enhancing accessibility to diagnostic services. For patients with chronic kidney disease (CKD) or those undergoing treatments that may impact kidney function, POCT allows for frequent and easy monitoring of creatinine levels, enabling timely adjustments to treatment plans. In telemedicine or remote healthcare settings, POCT of creatinine allows for remote monitoring of kidney function, promoting continuity of care and personalized treatment plans. POCT can lead to cost savings by reducing the need for multiple visits or sample transportation to centralized laboratories.

Key Market Players

• Abbott Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Quidel Corporation
• Cell Biolabs, Inc.
• Genway Biotech
• Randox Laboratories Ltd.
• ACON Laboratories
• Nova Biomedical
• Sysmex India Pvt. Ltd.

Report Scope:

In this report, the Global Creatinine Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Creatinine Assay Market, By Test Type:

• Jaffe Kinetic Method
• Enzymatic Method

Creatinine Assay Market, By Product:

• Reagents
• Kits

Creatinine Assay Market, By Sample:

• Blood/Serum
• Urine

Creatinine Assay Market, By End User:

• Hospitals
• Diagnostic Laboratories

Creatinine Assay Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Creatinine Assay Market.

Available Customizations:

Global Creatinine Assay market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Creatinine Assay Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Jaffe Kinetic Method, Enzymatic Method)
  • 5.2.2. By Product (Reagents, Kits)
  • 5.2.3. By Sample (Blood/Serum, Urine)
  • 5.2.4. By End User (Hospitals, Diagnostic Laboratories)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Creatinine Assay Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Product
  • 6.2.3. By Sample
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Creatinine Assay Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Sample
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Creatinine Assay Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Sample
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Creatinine Assay Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Sample
      • 6.3.3.2.4. By End User

7. Europe Creatinine Assay Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Product
  • 7.2.3. By Sample
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Creatinine Assay Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Sample
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Creatinine Assay Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Sample
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Creatinine Assay Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Sample
      • 7.3.3.2.4. By End User
  • 7.3.4. France Creatinine Assay Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Sample
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Creatinine Assay Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Sample
      • 7.3.5.2.4. By End User

8. Asia-Pacific Creatinine Assay Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Product
  • 8.2.3. By Sample
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Creatinine Assay Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Sample
      • 8.3.1.2.4. By End User
  • 8.3.2. India Creatinine Assay Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Sample
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Creatinine Assay Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Sample
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Creatinine Assay Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Sample
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Creatinine Assay Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Sample
      • 8.3.5.2.4. By End User

9. South America Creatinine Assay Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Product
  • 9.2.3. By Sample
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Creatinine Assay Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Sample
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Creatinine Assay Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Sample
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Creatinine Assay Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Sample
      • 9.3.3.2.4. By End User

10. Middle East and Africa Creatinine Assay Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Product
  • 10.2.3. By Sample
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Creatinine Assay Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Sample
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Creatinine Assay Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Sample
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Creatinine Assay Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Sample
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Creatinine Assay Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Thermo Fisher Scientific
• 14.3. Merck KGaA
• 14.4. Quidel Corporation
• 14.5. Cell Biolabs, Inc.
• 14.6. Genway Biotech
• 14.7. Randox Laboratories Ltd.
• 14.8. ACON Laboratories
• 14.9. Nova Biomedical
• 14.10. Sysmex India Pvt. Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer